Gabapentin for Insomnia Symptoms and Nighttime Vasomotor Symptoms (VMS) in Peri- and Postmenopausal Women
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The broad goal of this study is to obtain pilot data to determine the tolerability and
preliminary efficacy of the non-hormonal agent gabapentin for insomnia symptoms and nighttime
vasomotor Symptoms (VMS) when open-label gabapentin is administered at low dose and only at
night in peri- and postmenopausal women. We hypothesize that the majority of participants
will be able to increase and tolerate treatment, and insomnia symptoms and the frequency of
nighttime VMS will improve on low-dose gabapentin dosed at bedtime.
Phase:
N/A
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
Brigham and Women's Hospital National Institute on Aging (NIA)